DNAprint Genomics (DNAG)

[chiggah]

"Although Merck has insisted on keeping such details confidential, Dalton and two other Moffitt officials who worked on the M2Gen deal said last week that the agreement contains safeguards that protect the interests of Moffitt's researchers, patients and other stakeholders. It gives Moffitt and M2Gen freedom to do business with companies besides Merck, said Charles Resnick, a Moffitt board member who helped arrange the partnership."